2011
DOI: 10.1128/jcm.00867-10
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis B Virus (HBV) Infection and Recombination between HBV Genotypes D and E in Asymptomatic Blood Donors from Khartoum, Sudan

Abstract: Sudan is a highly endemic area for hepatitis B virus (HBV),Hepatitis B virus (HBV) infection remains a major health problem causing considerable morbidity and mortality despite the availability of vaccine and antiviral treatments. The World Health Organization (WHO) estimates that more than onethird of the world population is or has been in contact with the virus, resulting in Ͼ350 million HBV chronic carriers worldwide, with Ͼ18% of them living in Africa. Sudan is classified among the African countries with h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
76
2
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 61 publications
(92 citation statements)
references
References 33 publications
(50 reference statements)
12
76
2
2
Order By: Relevance
“…This result is high than a study carried out in Khartoum State for blood samples of donors where positive anti-HB core and positive HBsAg were 36% and 11% respectively (Mahgoub et al, 2011). The study among donors is selective and purposive compared to our study where sampling procedure infers the prevalence of HBV markers for White Nile State.…”
Section: Discussioncontrasting
confidence: 44%
See 1 more Smart Citation
“…This result is high than a study carried out in Khartoum State for blood samples of donors where positive anti-HB core and positive HBsAg were 36% and 11% respectively (Mahgoub et al, 2011). The study among donors is selective and purposive compared to our study where sampling procedure infers the prevalence of HBV markers for White Nile State.…”
Section: Discussioncontrasting
confidence: 44%
“…The infectivity of HBV is 50 to 100 times higher than HIV (WHO, 2012). Internationally; HBV is a leading cause of morbidity and mortality in the presence of the era of vaccines and antiviral treatment (Mahgoub, Candotti, El-Ekiaby, & Allain, 2011). Health-care workers are having the highest probability of being infected with HBV during medical career in health institutions (Deuffic-Burban, Delarocque-Astagneau, Abiteboul, Bouvet, & Yazdanpanah, 2011;Mele et al, 2001;De Schryver, Claesen, Meheus, van Sprundel, & François, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…OHB'li hastalarda genotip D'nin daha sık olduğunu gösteren ça-lışmalar olsa da farklı sonuçlar elde edilen çalışmalar da mevcuttur. [6][7][8][9][10]21]. Yapılan bazı çalışmalarda ise özellikle seronegatif OHB oluşumunda HBV X geninde mutasyonların etkisini düşündüren sonuçlar elde edilmiştir [38].…”
Section: Patogenez Ve Klinikunclassified
“…Pencere dönemi dışında HBsAg negatif iken HBsAg'ye karşı antikor (antiHBs) veya Hepatit B Core antijenine karşı immünglo-bülin G yapısında antikor (antiHBc IgG) varlığında veya yokluğunda, kan veya dokularda HBV DNA varlığı OHB olarak adlandı-rılır. OHB'li hastalarda serum HBV DNA düzeyi ise genellikle 10 4 kopya/ml'den düşük saptanır ve bu düzey HBsAg pozitif kişilere göre anlamlı olarak düşüktür [3,[6][7][8][9][10][11][12].…”
Section: Introductionunclassified
“…Internationally, HBV is at the top of other diseases regarding morbidity and mortality [1]. HBV is highly infectious.…”
Section: Background Informationmentioning
confidence: 99%